Most Popular Stories
- FDA maps out long-awaited rules for the biosimilars business
- FDA approvals of 2011
- Mouse study triggers demands for a possible Alzheimer's treatment
- High price of failure drives drug development costs into the stratosphere
- GSK, Takeda say nay to in-house diagnostics units
- Eisai loses panel vote on new Dacogen use
Webinars
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Featured Jobs
-
Sr. Manager, Market Research Job
Celgene Corporation - Summit, NJ, US -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US
Events
- World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C. - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - DCAT Week 2012
Mar 12-15 — New York City
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Evidence for the existence of stable-water-clusters at room temperature and normal pressure
- The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
- WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- Biosimilars: A Physician Perspective
Does having a non-scientist CEO negatively impact innovation at drug companies?
Yes
74%
No
26%
Total votes: 322
